KGMU urology scam: Medicines worth ₹5 lakh recovered from dismissed staffers’ lockers

The KGMU spokesperson said the inquiry committee is reconciling the recovered medicines with purchase and stock records

The probe into the multi-crore medicine scam in the KGMU Urology department intensified on Monday after the inquiry committee recovered medicines worth nearly ₹3 lakh from three lockers belonging to dismissed contractual employees. Earlier, medicines worth around ₹2 lakh had been found in another dismissed employee’s locker, taking the total recovery to about ₹5 lakh.

KGMU spokesperson Dr KK Singh said the inquiry committee is reconciling the recovered medicines with purchase and stock records, and action will be taken against any employee or official found involved in the irregularities.

The committee has seized the medicines and started matching them with procurement, stock and distribution records. Preliminary findings suggest the medicines were purchased under government-funded schemes, including Ayushman Bharat Yojna, the Chief Minister Relief Fund, the Prime Minister Relief Fund, and the Asadhya Yojana, but were found in employees’ lockers instead of reaching the patients.

The scam, involving medicines worth around ₹1.5 crore, has already led to the dismissal of three contractual employees, suspension of one pharmacist, removal of the Head of the Urology Department.

Related Posts

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction